In recent years, small volume biopsies have been increasingly utilized for diagnosis of tumors in both primary and recurrent settings. Concomitantly, the numbers of ancillary studies for ...
SELDI-TOF-MS technology is a combination of conventional choromatography and MS (Ciphergen Biosystems, CA, USA). The SELDI-TOF MS system, a modified MALDI-TOF-MS system, is an affinity-based MS method ...
The Biopsy Devices market is projected to reach $4.02 billion by 2033, growing from $2.43 billion in 2024 at a CAGR of 5.75%.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback